Skip to content

The Effects of Transcranial Direct Current Stimulation Combined with Esketamine on Perioperative Anxiety in Breast Cancer Patients

The Effects of Transcranial Direct Current Stimulation Combined with Esketamine on Perioperative Anxiety in Breast Cancer Patients

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500114512
Enrollment
Unknown
Registered
2025-12-15
Start date
2025-04-14
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perioperative anxiety

Interventions

Trial group 1:Patients in Experimental Group 1 underwent pre - operative transcranial direct current stimulation. Anodal stimulation was applied to the left dorsolateral prefrontal cortex, and cathoda
Trial group 2:Patients in Experimental Group2 underwent pre - operative sham transcranial direct current stimulation. Anodal stimulation was applied to the left dorsolateral prefrontal cortex, and ca
Trial group 3:Patients in Experimental Group 3 underwent pre - op transcranial direct current stimulation. Anodal stimulation was applied to the left dorsolateral prefrontal cortex, and cathodal to th
Control group:Patients in the control group underwent pre - op sham transcranial direct current stimulation. Anodal stimulation was applied to the left dorsolateral prefrontal cortex, and cathodal to

Sponsors

Longyan First Affiliated Hospital of Fujian Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 - 65. 2. ASA physical status ? - ?. 3. Patients undergoing elective breast cancer surgery.

Exclusion criteria

Exclusion criteria: 1. Patients refusing to sign the consent form or unable to comprehend the questionnaire. 2. Patients with neuropsychiatric disorders or a history of such. 3. Patients with cranial or scalp injuries. 4. Patients with severe cardiovascular disease. 5. Patients with severe liver or kidney dysfunction. 6. Patients with severe respiratory disease. 7. Patients with metal implants. 8. Patients with chronic pain on long-term analgesics or psychotropic drugs (including opioids, NSAIDs, sedatives, and antidepressants). 9. Patients with severe arrhythmias or neuromuscular disorders. 10. Patients allergic to esketamine. 11. Patients with glaucoma. 12. Patients with untreated or inadequately treated hyperthyroidism.

Design outcomes

Primary

MeasureTime frame
Incidence of perioperative anxiety;

Secondary

MeasureTime frame
The incidence rate of postoperative nausea and vomiting (PONV).;Pain score;Postoperative fatigue.;Sleep quality score.;Quality of post-operative recovery;Blood indicators possibly related to perioperative anxiety (fibrinogen, PLT, MPV, PDW, hematocrit);Postoperative rescue analgesic measures;Record the duration of surgery, duration of anesthesia, volume of fluid infusion, type of surgery, recovery time, postoperative extubation time, PACU stay duration, and hospitalization time;

Countries

China

Contacts

Public ContactLi Shihai

Longyan First Affiliated Hospital of Fujian Medical University

13959002329@139.com+86 139 5900 2329

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026